Olanzapine and sulpiride: A preliminary study of combination/augmentation in patients with treatment-resistant schizophrenia

Journal of Clinical Psychopharmacology

Volumn 20, Issue 5, 2000, Pages 500-503

  Raskin, Sergey ^a   Durst, Rimona ^a,b   Katz, Gregory ^a   Zislin, Josef ^a  

^a HEBREW UNIVERSITY   (Israel)

^b Jerusalem Mental Health Center Ezrath Nashim   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN RECEPTOR; CLOZAPINE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; NEUROLEPTIC AGENT; OLANZAPINE; SULPIRIDE;

ARTICLE; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RATING SCALE; SCHIZOPHRENIA; SIDE EFFECT;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PIRENZEPINE; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SULPIRIDE;

EID: 0033835651     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200010000-00002     Document Type: Article

References (26)

1. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders
2. Sulpiride adjunction to clozapine in treatment-resistant schizophrenic patients: A preliminary case series study
3. Sulpiride augmentation in people with schizophrenia partially responsive to clozapine
4. In vitro and in vivo biochemistry of olanzapine: A novel, atypical antipsychotic drug
5. Efficacy of olanzapine: An overview of pivotal clinical trials
6. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreni-form disorders: Results of an international collaborative trial
7. Clozapine: A review of its pharmacological properties and therapeutic use in patients with schizophrenia who are unresponsive to or intolerant of classic antipsychotic agents
8. Plasma clozapine concentrations as a predictor of clozapine response
9. Sulpiride augmentation on schizophrenia
10. Clozapine related seizures
11. Reflux oesophagitis and clozapine
12. Acute pancreatitis associated with clozapine use
13. Clozapine and associated diabetes mellitus
14. Hepatotoxicity of clozapine
15. Hypertension after initiation of clozapine
16. Paradoxical hypertension associated with clozapine
17. Clozapine: A mimicry of phaeochromocytoma
18. Lactic acidosis and fatal myocardial failure due to clozapine
19. Clinical predictors of acute response with olanzapine in psychotic mood disorders
20. Olanzapine. Interaction study with imipramine
21. Clinical evaluation of sulpiride in schizophrenic patients - A double-blind comparison with chlorpromazine
22. Sulpiride in tardive dyskinesia
23. Role of serotonin in the action of atypical antipsychotic drugs
24. A comparison of the covalent binding of clozapine and olanzapine to human neutrophils in vitro and in vivo
25. Similarities and differences between the subchronic and withdrawal effects of clozapine and olanzapine on forelimb force steadiness
26. Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia